Koki Hikami

519 total citations
13 papers, 409 citations indexed

About

Koki Hikami is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Koki Hikami has authored 13 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Rheumatology. Recurrent topics in Koki Hikami's work include Cell Adhesion Molecules Research (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Koki Hikami is often cited by papers focused on Cell Adhesion Molecules Research (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Koki Hikami collaborates with scholars based in Japan and United States. Koki Hikami's co-authors include Naoyuki Tsuchiya, Aya Kawasaki, Katsushi Tokunaga, Jun Ohashi, Yoshinari Takasaki, Hiroshi Hashimoto, Ikue Ito, Timothy W. Behrens, Shinichi Sato and Minoru Hasegawa and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and International Journal of Obesity.

In The Last Decade

Koki Hikami

12 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koki Hikami Japan 9 258 177 100 89 61 13 409
Trieneke C. G. Timmer Netherlands 6 174 0.7× 254 1.4× 81 0.8× 74 0.8× 68 1.1× 8 442
Lubing Zhu China 4 401 1.6× 268 1.5× 55 0.6× 45 0.5× 50 0.8× 5 504
Niklas Hagberg Sweden 14 407 1.6× 285 1.6× 93 0.9× 32 0.4× 80 1.3× 21 533
L Truedsson Sweden 8 481 1.9× 374 2.1× 100 1.0× 42 0.5× 78 1.3× 13 617
Mikhail Olferiev United States 6 260 1.0× 160 0.9× 77 0.8× 33 0.4× 115 1.9× 11 388
Ulf M�ller-Ladner Germany 6 116 0.4× 96 0.5× 59 0.6× 119 1.3× 77 1.3× 8 322
L A Lee United States 7 148 0.6× 205 1.2× 35 0.3× 66 0.7× 80 1.3× 7 338
F Navaux France 6 133 0.5× 202 1.1× 65 0.7× 36 0.4× 51 0.8× 9 357
K Dalwigk Austria 9 400 1.6× 315 1.8× 121 1.2× 32 0.4× 92 1.5× 17 577
Mingzeng Zhang Japan 10 280 1.1× 158 0.9× 50 0.5× 18 0.2× 98 1.6× 15 410

Countries citing papers authored by Koki Hikami

Since Specialization
Citations

This map shows the geographic impact of Koki Hikami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koki Hikami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koki Hikami more than expected).

Fields of papers citing papers by Koki Hikami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koki Hikami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koki Hikami. The network helps show where Koki Hikami may publish in the future.

Co-authorship network of co-authors of Koki Hikami

This figure shows the co-authorship network connecting the top 25 collaborators of Koki Hikami. A scholar is included among the top collaborators of Koki Hikami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koki Hikami. Koki Hikami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Inoue, Yasumichi, Koki Hikami, Shunsuke Ebara, et al.. (2025). Abstract 1745: Combining HRI/PERK/GCN2 inhibitor CRD-799 with proteasome inhibitors provides a novel approach to overcoming resistance in multiple myeloma treatment. Cancer Research. 85(8_Supplement_1). 1745–1745.
2.
Inoue, Yasumichi, Koki Hikami, Shunsuke Ebara, et al.. (2024). Abstract 1233: Novel inhibitor targeting triple integrated stress response kinase HRI, PERK, and GCN2 provides new insights into overcoming resistance to proteasome inhibitors in multiple myeloma. Cancer Research. 84(6_Supplement). 1233–1233. 1 indexed citations
3.
Naka, Izumi, Koki Hikami, Kazuhiro Nakayama, et al.. (2012). A functional SNP upstream of the beta-2 adrenergic receptor gene (ADRB2) is associated with obesity in Oceanic populations. International Journal of Obesity. 37(9). 1204–1210. 10 indexed citations
4.
Koga, Minori, et al.. (2012). Effects ofAPRIL(TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL. Modern Rheumatology. 22(4). 541–549. 9 indexed citations
5.
Koga, Minori, et al.. (2011). Effects of APRIL (TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL. Modern Rheumatology. 22(4). 541–549. 9 indexed citations
6.
Honda, Kohei, Koki Hikami, Hitoshi Miyashita, et al.. (2011). Abstract A207: Discovery of molecular mechanisms underlying cellular sensitivity to the PLK1 inhibitor TAK-960.. Molecular Cancer Therapeutics. 10(11_Supplement). A207–A207. 1 indexed citations
7.
Hikami, Koki, Aya Kawasaki, Ichiaki Ito, et al.. (2010). Association of a functional polymorphism in the 3′-untranslated region of SPI1 with systemic lupus erythematosus. Arthritis & Rheumatism. 63(3). 755–763. 44 indexed citations
8.
Ito, Ikue, Yasushi Kawaguchi, Aya Kawasaki, et al.. (2009). Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Arthritis & Rheumatism. 60(6). 1845–1850. 90 indexed citations
9.
Kawasaki, Aya, Chieko Kyogoku, Jun Ohashi, et al.. (2008). Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: Support for a crucial role of intron 1 polymorphisms. Arthritis & Rheumatism. 58(3). 826–834. 86 indexed citations
10.
Hikami, Koki, Minoru Hasegawa, Manabu Fujimoto, et al.. (2008). Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis. Biochemical and Biophysical Research Communications. 373(3). 403–407. 31 indexed citations
11.
Kawasaki, Aya, Ikue Ito, Koki Hikami, et al.. (2008). Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4region. Arthritis Research & Therapy. 10(5). R113–R113. 74 indexed citations
12.
Hikami, Koki, et al.. (2003). Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population. Genes and Immunity. 4(2). 160–167. 46 indexed citations
13.
Hikami, Koki, Naoyuki Tsuchiya, & Katsushi Tokunaga. (2000). New variations in human OX40 ligand (CD134L) gene. Genes and Immunity. 1(8). 521–522. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Trieneke C. G. Timmer Breakdown of academic impact, for papers by Lubing Zhu Breakdown of academic impact, for papers by Niklas Hagberg Breakdown of academic impact, for papers by L Truedsson Breakdown of academic impact, for papers by Mikhail Olferiev Breakdown of academic impact, for papers by Ulf M�ller-Ladner Breakdown of academic impact, for papers by L A Lee Breakdown of academic impact, for papers by F Navaux Breakdown of academic impact, for papers by K Dalwigk Breakdown of academic impact, for papers by Mingzeng Zhang
Rankless by CCL
2026